Healthy Returns: AbbVie is the newest potential we... CNBC

Healthy Returns: AbbVie is the newest potential weight loss drug market player

Source: CNBC | Published: March 4, 2025, 7:59 p.m.

AbbVie will pay up to $2.2 billion to develop Danish drugmaker Gubra's obesity drug. AI takes center stage at HIMSS conference gets underway in Vegas.
Read Original Article Back to News List

Related News

Read Hertz CEO's letter to employees about Bill Ackman's 'significant' stake in the rental car firm
12 hours, 43 minutes ago
Trump renews call for interest rate cut, says rates would be lower if Fed chief Powell 'understood what he was doing'
16 hours, 23 minutes ago
Capital One and Discover merger approved by Federal Reserve
17 hours, 8 minutes ago
Nintendo Switch 2 retail preorder to begin April 24 following tariff delays
19 hours, 3 minutes ago
U.S. proposes lighter sanctions on Russia as part of peace plan with Ukraine: Bloomberg
19 hours, 54 minutes ago